• <input id="ycg2u"></input>
    <legend id="ycg2u"></legend>
    <strong id="ycg2u"><u id="ycg2u"></u></strong>
  • Enable Accessibility Enable Accessibility

    About T-CiRA


    Collaborative research aiming to develop innovative treatments over a 10-year period

    T-CiRA is a joint research program by the Center for iPS Cell Research and Application (CiRA), Kyoto University and Takeda Pharmaceutical Company Limited. Over a 10-year period and under the direction of CiRA, this joint program will conduct research to develop clinical applications of iPS cells. We aim to develop innovative drugs and cell treatments in such areas as heart failure, diabetes mellitus, neuro-psychiatric disorders, cancer and intractable muscle diseases in order to fulfill the needs of patients promptly.

    web_icon_vision.png

    Our vision:
    the long-term goal that we strive to reach.

    A world with the prospect of
    Better Health through the infinite Power of Science


    web_icon_purpose.png

    Our purpose:
    why we exist as an organization.


    Transform medicine with the unlimited potential of
    iPS cells


    web_icon_mission.png

    Our mission:
    how we accomplish our purpose.


    Discover the seeds of treatment options
    and nurture them for clinical application


    web_icon_identity.png

    Our identity:
    who we are.


    I
    NNOVATORS
    Opening up new possibilities in healthcare without fear of failure

    P
    IONEERS
    Always keeping up with patients’ needs using the wisdom of science

    S
    CIENTISTS
    Conducting next-generation research for drug discovery within an industry-academia collaboration


    T-CiRA_logo.png

    3logos.png

    10year.png

    200billion.png

    10project.png

    100man.png

    Research area_E.png



    button_pdf_E.png

    国产AV网站_中午文字幕av一区二区三区_性进入裸体视频_久久久久久精品免费免费直播